ORIGINAL ARTICLE
Ahead of Print

Prostate volume does not provide additional predictive value to prostate health index for prostate cancer or clinically significant prostate cancer: results from a multicenter study in China


1 Department of Urology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China
2 Department of Urology, Huashan Hospital, Fudan University, Shanghai 200040, China
3 Fudan Institute of Urology, Huashan Hospital, Fudan University, Shanghai 200040, China
4 Department of Urology, Shanghai Cancer Center, Fudan University, Shanghai 200032, China
5 Department of Urology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China
6 Division of Urology, NorthShore University Health System, Evanston, IL 60201, USA
7 Program for Personalized Cancer Care, NorthShore University Health System, Evanston, IL 60201, USA
8 Department of Urology, Shanghai Changhai Hospital, The Second Military Medical University, Shanghai 200433, China

Correspondence Address:
Dan-Feng Xu,
Department of Urology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China

Rong Na,
Department of Urology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China; Program for Personalized Cancer Care, NorthShore University Health System, Evanston, IL 60201, USA

Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/1008-682X.275509

PMID: 31929198

To evaluate whether prostate volume (PV) would provide additional predictive utility to the prostate health index (phi) for predicting prostate cancer (PCa) or clinically significant prostate cancer, we designed a prospective, observational multicenter study in two prostate biopsy cohorts. Cohort 1 included 595 patients from three medical centers from 2012 to 2013, and Cohort 2 included 1025 patients from four medical centers from 2013 to 2014. Area under the receiver operating characteristic curves (AUC) and logistic regression models were used to evaluate the predictive performance of PV-based derivatives and models. Linear regression analysis showed that both total prostate-specific antigen (tPSA) and free PSA (fPSA) were significantly correlated with PV (all P < 0.05). [-2]proPSA (p2PSA) was significantly correlated with PV in Cohort 2 (P< 0.001) but not in Cohort 1 (P= 0.309), while no significant association was observed between phi and PV. When combining phi with PV, phi density (PHID) and another phi derivative (PHIV, calculated as phi/PV0.5) did not outperform phi for predicting PCa or clinically significant PCa in either Cohort 1 or Cohort 2. Logistic regression analysis also showed that phi and PV were independent predictors for both PCa and clinically significant PCa (all P < 0.05); however, PV did not provide additional predictive value to phi when combining these derivatives in a regression model (all models vs phi were not statistically significant, all P > 0.05). In conclusion, PV-based derivatives (both PHIV and PHID) and models incorporating PV did not improve the predictive abilities of phi for either PCa or clinically significant PCa.


[FULL TEXT] [PDF]
Print this article
Search
 Back
 
  Search Pubmed for
 
    -  Huang D
    -  Wu YS
    -  Ye DW
    -  Qi J
    -  Liu F
    -  Helfand BT
    -  Zheng SL
    -  Ding Q
    -  Xu DF
    -  Na R
    -  Xu JF
    -  Sun YH
 Citation Manager
 Article Access Statistics
 Reader Comments
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed2285    
    PDF Downloaded451    

Recommend this journal